Pharmacogenomic-Guided Therapy in Colorectal Cancer.

Clinical Pharmacology and Therapeutics
Robert B DiasioSteven M Offer

Abstract

Approximately 20 drugs have been shown to be effective for the treatment of colorectal cancer (CRC). These drugs are from several classes of agents and include cytotoxic drugs, therapeutics that target cell signaling pathways at the extracellular and/or intracellular levels, and combination therapies that contain multiple targeted agents and/or cytotoxic compounds. Targeted therapeutics can include monoclonal antibodies, fusion proteins, and small molecule drugs. The first introduced into clinical use was 5-fluorouracil in the early 1960s and remains the foundation for most CRC treatments in both adjuvant therapy and in advanced (metastatic) treatment regimens. As with other cancers, the consideration of biomarkers has the potential to improve CRC therapy through patient stratification. The biomarkers can include germline genetic markers, tumor-specific genetic markers, immune markers, and other biomarkers that can predict antitumor efficacy or the likelihood of toxicity prior to administration of a specific drug. Consistent with the benefit of considering biomarkers in treatment, many newer targeted therapies are developed and approved simultaneously with a companion diagnostic test to determine efficacy. This review will focu...Continue Reading

References

Apr 1, 1989·Clinical Pharmacokinetics·R B Diasio, B E Harris
Mar 10, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Federico InnocentiMark J Ratain
Jun 4, 2004·The New England Journal of Medicine·Herbert HurwitzFairooz Kabbinavar
Sep 10, 2004·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Thierry LecomtePierre Laurent-Puig
Dec 16, 2005·Nature·Napoleone Ferrara, Robert S Kerbel
Oct 15, 1958·Proceedings of the National Academy of Sciences of the United States of America·S S CohenJ Lichtenstein
Apr 19, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Leonard B SaltzJim Cassidy
Mar 24, 2009·Lancet·Louis M WeinerSoldano Ferrone
Jan 27, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Alberto Bardelli, Salvatore Siena
Jun 2, 2011·Nature Reviews. Drug Discovery·Vernon K SondakPeter Kirkpatrick
Sep 15, 2012·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Patricia A TangMalcolm J Moore
Apr 17, 2013·Clinical Pharmacology and Therapeutics·S M OfferR B Diasio
Sep 17, 2013·Clinical Pharmacology and Therapeutics·A ZaananC Narjoz
Oct 11, 2013·Clinical Pharmacology and Therapeutics·S M Offer, R B Diasio
Nov 9, 2014·Journal of the National Cancer Institute·Adam M LeeRobert B Diasio
Mar 11, 2015·Therapeutic Advances in Medical Oncology·Douglas B JohnsonJeffrey A Sosman
Oct 4, 2015·Nature·UNKNOWN 1000 Genomes Project ConsortiumGonçalo R Abecasis
Nov 18, 2015·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Maarten J DeenenJan H M Schellens
Apr 20, 2016·Annals of Oncology : Official Journal of the European Society for Medical Oncology·G FolprechtJ R Zalcberg
Dec 7, 2017·The Lancet Oncology·Nicholas L SynRoss A Soo
Jan 13, 2018·Clinical Pharmacology and Therapeutics·Shikshya ShresthaRobert B Diasio
Jan 23, 2018·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Michael J OvermanThierry André
Dec 14, 2018·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Linda M HenricksJan H M Schellens
Dec 18, 2018·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Patrick A OttJared K Lunceford

❮ Previous
Next ❯

Citations

Aug 20, 2021·Clinical Pharmacology and Therapeutics·Sara L Van Driest, Ingolf Cascorbi

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.